vimarsana.com

Latest Breaking News On - Investigacio biomedica - Page 1 : vimarsana.com

Synthetic Biologics Reports First Quarter 2022 Operational

-Encouraging data further supports the development of novel oncolytic adenovirus (OV) platform; Announced a peer-reviewed publication highlighting positive.

United-states
Hebron
Israel-general
Israel
American
Frank-tufaro
Stevena-shallcross
Daniel-dimaio
Investigacio-biomedica
Ramon-alemany
Manel-cascall
Marks-blumenkranz

2022-05-05 | NYSEAM:SYN | Press Release | Synthetic Biologics Inc.

(2022-05-05 | NYSEAM:SYN) Synthetic Biologics Announces Formation of Scientific Advisory Board to Advance Oncology Pipeline

Colorado
United-states
Hebron
Israel-general
Israel
Spain
Texas
Barcelona
Comunidad-autonoma-de-cataluna
American
Tabernero-closecurlyquote
Stevena-shallcross

Synthetic Biologics Announces Formation of Scientific

Scientific Advisory Board of leading experts in oncolytic adenoviruses and gene therapies strengthens transformative clinical development strategy and.

Colorado
United-states
Hebron
Israel-general
Israel
Spain
Texas
Barcelona
Comunidad-autonoma-de-cataluna
American
Stevena-shallcross
Daniel-dimaio

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.